Phase I primarily addresses safety and dosage. In contrast, Phase II expands to evaluate the treatment's effectiveness while continuing to monitor safety. Phase III will later confirm effectiveness on a larger scale and compare the new treatment to current standard treatments, and Phase IV involves post-market surveillance to gather additional information on the treatment's risks and benefits.
